
Ben S. Michelson
Examiner (ID: 19370, Phone: (571)270-1164 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 286 |
| Issued Applications | 177 |
| Pending Applications | 1 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9538350
[patent_doc_number] => 20140162997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'SUBSTITUTED PYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS'
[patent_app_type] => utility
[patent_app_number] => 13/968465
[patent_app_country] => US
[patent_app_date] => 2013-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21854
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13968465
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/968465 | Substituted pyrazoles as N-type calcium channel blockers | Aug 15, 2013 | Issued |
Array
(
[id] => 9192054
[patent_doc_number] => 20130331369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => '3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists'
[patent_app_type] => utility
[patent_app_number] => 13/962689
[patent_app_country] => US
[patent_app_date] => 2013-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 57375
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13962689
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/962689 | 3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists | Aug 7, 2013 | Abandoned |
Array
(
[id] => 11799578
[patent_doc_number] => 09540366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Ring-fused heterocyclic compound'
[patent_app_type] => utility
[patent_app_number] => 14/418253
[patent_app_country] => US
[patent_app_date] => 2013-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73863
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418253
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/418253 | Ring-fused heterocyclic compound | Jul 30, 2013 | Issued |
Array
(
[id] => 10354906
[patent_doc_number] => 20150239911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'METHOD FOR PRODUCING COMPLEX COMPOSED OF ORGANIC NITROGEN COMPOUND AND COPPER (I) SALT OF FLUOROOXO ACID'
[patent_app_type] => utility
[patent_app_number] => 14/431739
[patent_app_country] => US
[patent_app_date] => 2013-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5009
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431739
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431739 | METHOD FOR PRODUCING COMPLEX COMPOSED OF ORGANIC NITROGEN COMPOUND AND COPPER (I) SALT OF FLUOROOXO ACID | Jul 21, 2013 | Abandoned |
Array
(
[id] => 10070580
[patent_doc_number] => 09108923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Compounds, compositions, and methods for cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 13/946959
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 34811
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946959
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/946959 | Compounds, compositions, and methods for cancer therapy | Jul 18, 2013 | Issued |
Array
(
[id] => 9570075
[patent_doc_number] => 20140187786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => '1,3,4-TRISUBSTITUTED BENZENES'
[patent_app_type] => utility
[patent_app_number] => 13/945500
[patent_app_country] => US
[patent_app_date] => 2013-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49324
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/945500 | 1,3,4-TRISUBSTITUTED BENZENES | Jul 17, 2013 | Abandoned |
Array
(
[id] => 10347473
[patent_doc_number] => 20150232478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'COMPOUND HAVING AGONISTIC ACTIVITY ON SOMATOSTATIN RECEPTOR, AND USE THEREOF FOR MEDICAL PURPOSES'
[patent_app_type] => utility
[patent_app_number] => 14/412564
[patent_app_country] => US
[patent_app_date] => 2013-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68869
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412564
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412564 | Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes | Jul 1, 2013 | Issued |
Array
(
[id] => 9462709
[patent_doc_number] => 20140127137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS'
[patent_app_type] => utility
[patent_app_number] => 13/919923
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 33059
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13919923
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/919923 | SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS | Jun 16, 2013 | Abandoned |
Array
(
[id] => 11343458
[patent_doc_number] => 09527853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Fused triazole derivatives as gamma secretase modulators'
[patent_app_type] => utility
[patent_app_number] => 14/406386
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21565
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406386
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406386 | Fused triazole derivatives as gamma secretase modulators | Jun 13, 2013 | Issued |
Array
(
[id] => 9254879
[patent_doc_number] => 08618296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-31
[patent_title] => 'Arylethynyl derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/914336
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38626
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914336
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/914336 | Arylethynyl derivatives | Jun 9, 2013 | Issued |
Array
(
[id] => 10214766
[patent_doc_number] => 20150099758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/398968
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14634
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398968
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398968 | Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof | May 7, 2013 | Abandoned |
Array
(
[id] => 9832084
[patent_doc_number] => 08940901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/889761
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6500
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889761
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/889761 | Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives | May 7, 2013 | Issued |
Array
(
[id] => 11761917
[patent_doc_number] => 09370184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-21
[patent_title] => '6-pyridone-2-carbamoyl-azoles and their use as herbicides'
[patent_app_type] => utility
[patent_app_number] => 14/397676
[patent_app_country] => US
[patent_app_date] => 2013-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16129
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397676
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/397676 | 6-pyridone-2-carbamoyl-azoles and their use as herbicides | Apr 29, 2013 | Issued |
Array
(
[id] => 11737084
[patent_doc_number] => 09701658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Amide derivatives as TTX-S blockers'
[patent_app_type] => utility
[patent_app_number] => 14/391241
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47855
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391241
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/391241 | Amide derivatives as TTX-S blockers | Apr 24, 2013 | Issued |
Array
(
[id] => 9016525
[patent_doc_number] => 20130231489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'NOVEL ORGANOMETALLIC COMPLEXES WHICH EMIT IN THE RED TO GREEN SPECTRAL REGION AND THEIR USE IN OLEDS'
[patent_app_type] => utility
[patent_app_number] => 13/863407
[patent_app_country] => US
[patent_app_date] => 2013-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10543
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13863407
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/863407 | Organometallic complexes which emit in the red to green spectral region and their use in OLEDs | Apr 15, 2013 | Issued |
Array
(
[id] => 9004699
[patent_doc_number] => 20130225824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'PRODUCTION PROCESS OF OPTICALLY ACTIVE 3-QUINUCLIDINOL DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/858586
[patent_app_country] => US
[patent_app_date] => 2013-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7506
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858586
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/858586 | Production process of optically active 3-quinuclidinol derivative | Apr 7, 2013 | Issued |
Array
(
[id] => 9910142
[patent_doc_number] => 20150065345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => '1,2,4 - TRIAZOLE DERIVATIVES AS HERBICIDALS'
[patent_app_type] => utility
[patent_app_number] => 14/389141
[patent_app_country] => US
[patent_app_date] => 2013-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7373
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389141
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389141 | 1,2,4 - TRIAZOLE DERIVATIVES AS HERBICIDALS | Mar 26, 2013 | Abandoned |
Array
(
[id] => 10234434
[patent_doc_number] => 20150119429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'Iron Chelators as HIV-1 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/399646
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9507
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399646
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399646 | Iron Chelators as HIV-1 Inhibitors | Mar 13, 2013 | Abandoned |
Array
(
[id] => 8925442
[patent_doc_number] => 20130181202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'PHOTOELECTRIC CONVERSION MATERIAL, FILM CONTAINING THE MATERIAL, PHOTOELECTRIC CONVERSION DEVICE, METHOD FOR PREPARING PHOTOELECTRIC CONVERSION DEVICE, METHOD FOR USING PHOTOELECTRIC CONVERSION DEVICE, PHOTOSENSOR AND IMAGING DEVICE'
[patent_app_type] => utility
[patent_app_number] => 13/789537
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35383
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789537
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/789537 | Photoelectric conversion material, film containing the material, photoelectric conversion device, method for preparing photoelectric conversion device, method for using photoelectric conversion device, photosensor and imaging device | Mar 6, 2013 | Issued |
Array
(
[id] => 8916831
[patent_doc_number] => 20130178456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'ARYLETHYNYL DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/779782
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38593
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13779782
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/779782 | Arylethynyl derivatives | Feb 27, 2013 | Issued |